Basnec 2005.

Study characteristics
Methods	Placebo‐controlled, parallel‐group, double‐blind randomised controlled trial
Participants	Participants between three and 11 years of age with a diagnosis of BECTS who had experienced only one seizure and had received no AED 34 participants were randomly assigned. Unclear how many participants were allocated to each group Males versus females—not stated
Interventions	Sulthiame versus placebo
Outcomes	Proportion of participants withdrawing from treatment Proportion of participants experiencing a second seizure within six months Proportion of participants experiencing a second seizure after six months Proportion of participants experiencing status epilepticus
Notes	At the time of publication of this review, a full‐text English translation is unavailable, and the above information is taken from the English translation of the abstract only
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Unable to fully assess risk of bias because of lack of English language full‐text manuscript
Allocation concealment (selection bias)	Unclear risk	Unable to fully assess risk of bias because of lack of English language full‐text manuscript
Blinding of participants and personnel (performance bias) All outcomes	Unclear risk	Unable to fully assess risk of bias because of lack of English language full‐text manuscript
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Unable to fully assess risk of bias because of lack of English language full‐text manuscript
Incomplete outcome data (attrition bias) All outcomes	Unclear risk	Unable to fully assess risk of bias because of lack of English language full‐text manuscript
Selective reporting (reporting bias)	Unclear risk	Unable to fully assess risk of bias because of lack of English language full‐text manuscript
Other bias	Unclear risk	Unable to fully assess risk of bias because of lack of English language full‐text manuscript